Project/Area Number |
23590934
|
Research Category |
Grant-in-Aid for Scientific Research (C)
|
Allocation Type | Multi-year Fund |
Section | 一般 |
Research Field |
Gastroenterology
|
Research Institution | Tokyo Medical and Dental University |
Principal Investigator |
FUJII TOSHIMITSU 東京医科歯科大学, 医学部附属病院, 助教 (30547451)
|
Co-Investigator(Kenkyū-buntansha) |
WATANABE Mamoru 東京医科歯科大学, 医歯学総合研究科, 教授 (10175127)
永石 宇司 東京医科歯科大学, 医学部附属病院, 助教 (60447464)
|
Co-Investigator(Renkei-kenkyūsha) |
NAGAISHI Takashi 東京医科歯科大学, 医学部附属病院, 助教 (60447464)
|
Project Period (FY) |
2011 – 2013
|
Project Status |
Completed (Fiscal Year 2013)
|
Budget Amount *help |
¥5,070,000 (Direct Cost: ¥3,900,000、Indirect Cost: ¥1,170,000)
Fiscal Year 2013: ¥1,430,000 (Direct Cost: ¥1,100,000、Indirect Cost: ¥330,000)
Fiscal Year 2012: ¥1,430,000 (Direct Cost: ¥1,100,000、Indirect Cost: ¥330,000)
Fiscal Year 2011: ¥2,210,000 (Direct Cost: ¥1,700,000、Indirect Cost: ¥510,000)
|
Keywords | 炎症性腸疾患 / 慢性腸炎 / リンパ球動態制御 / FTY720 / S1P受容体 |
Research Abstract |
In inflammatory bowel diseases, it is thought that colitogenic memory CD4+ T cells are intermittently reactivated in regional lymphoid organs, and return to inflammatory tissues. Little is known about how FTY720 controls the migration property of memory T cells. We here demonstrated that FTY720 prevents the development of colitis induced by the adoptive transfer of naive CD4+ T cells into SCID mice. Also FTY720 prevents the colitis induced by the adoptive transfer of colitogenic effector-memory CD4+ T cells into SCID mice. In both model, cell number of CD4+ T cells was markedly decreased in peripheral blood of FTY720-treated mice, but conversely increased in lymph nodes. Notably, FTY720 treatment prevented the development of colitis in inflammatory bowel disease model by inhibition of T-cell egress from lymph nodes.
|